This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services as per § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS 'Healthy Back' program. This will be conducted under an 'Open House' model, allowing multiple suppliers to participate. Suppl
Tender closed on 15 Sept 2025. Awaiting award.
This contract opportunity involves establishing non-exclusive discount agreements for the drug Fampridine, as per German law. The agreements will be made available through an Open House model, allowing all interested pharmaceutical companies to participate if they meet the requirements. There will b
This contract opportunity involves establishing non-exclusive discount agreements for the medication Beclometasone/Formoterol (ATC Code: R03AK08), excluding the dosage of 100µg/6µg as a metered-dose aerosol. The agreements will be made under an Open-House model, allowing all interested pharmaceutica
This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services as per § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Nutritional Counseling" under an "Open House Model". The services include individual consultations for patients at v
This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services in accordance with § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Healthy Back". The services will include conducting courses for patients at various locations in Saxony
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
